US Patent Issued to TerSera Therapeutics on June 16 for "Methods of reducing the likelihood of carcinoid heart disease in patients with neuroendocrine tumors" (Illinois, Oregon Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,826, issued on June 16, was assigned to TerSera Therapeutics LLC (Deerfield, Ill.).

"Methods of reducing the likelihood of carcinoid heart disease in patients with neuroendocrine tumors" was invented by Lonnie Brent (Deerfield, Ill.) and Janine North (Eugene, Ore.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are methods of treating a human patient with a newly diagnosed neuroendocrine tumor, methods of treating patients with neuroendocrine tumors with early signs of carcinoid heart disease who have not had a heart valve replacement, and methods of treating a human patient with the neuroendocrine tumor who has had a recent heart va...